SVICHER, VALENTINA
SVICHER, VALENTINA
Dipartimento di Biologia
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-01 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-02 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study
2016-07-01 Nozza, S; Pignataro, Ar; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection.
2015-01-01 Aragri, M; Coppola, N; Alteri, C; Battisti, A; Sagnelli, C; Pisaturo, M; Bellocchi, M; Salpini, R; Starace, M; Armenia, D; Carioti, L; Pollicita, M; Sagnelli, E; Perno, C; Svicher, V
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro
2020-02-23 Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy
2015-01-01 Pollicita, M; Alteri, C; Bellocchi, M; Armenia, D; Carioti, L; Salpini, R; Colagrossi, L; Battisti, A; Aragri, M; Fabeni, L; Mariani, R; Dalessandro, M; Ranelli, A; Paoloni, M; Parruti, G; Perno, Cf; Svicher, V
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
2019-07-26 Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART.
2014-08-01 Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, A; Calvez, V; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Santoro, M
Acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer, hampers HBsAg stability and secretion and promotes cell survival
2022-01-01 Piermatteo, L; Carioti, L; Leoni, G; Duca, L; Saccomandi, P; Stella, D; Andreassi, E; Bertoli, A; Cappiello, G; Fleury, H; Svicher, V; Salpini, R
Amino acid variability of small molecule inhibitors and mAbs target sites in globally circulating RSV strains
2023-01-01 Fox, V; Scutari, R; Salpini, R; La Frazia, S; Bandera, A; Priralla, A; Periani, E; Gori, A; Svicher, V; Alteri, C
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein.
2022-01-01 Bellocchi, Mc; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F
An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression
2021-04-02 Brancaccio, G; Salpini, R; Piermatteo, L; Surdo, M; Fini, V; Colagrossi, L; Cantone, M; Battisti, A; Oda, Y; Di Carlo, D; Ceccherini-Silberstein, F; Perno, Cf; Gaeta, Gb; Svicher, V
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen
2013-06-22 Cento, V; Van Hemert, F; Neumann Fraune, M; Mirabelli, C; Di Maio, V; Salpini, R; Bertoli, A; Micheli, V; Gubertini, G; Romano, S; Visca, M; De Sanctis, G; Berkhout, B; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy
2024-01-01 Malagnino, V; Cozzi‐lepri, A; Svicher, V; Girardi, E; Perno, C; Saracino, A; Cuomo, G; Rusconi, S; Puoti, M; D'Arminio Monforte, A; Andreoni, M; Sarmati, L
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy
2019-01-01 Grande, F; Occhiuzzi, Ma; Rizzuti, B; Ioele, G; De Luca, M; Tucci, P; Svicher, V; Aquaro, S; Garofalo, A
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors
2007-10-01 CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
2011-01-01 Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf
Characterization of novel HIV drug resistance mutations using clustering, multidimensional scaling and SVM-based feature ranking
2005-01-01 Sing, T; Svicher, V; Beerenwinkel, N; CECCHERINI SILBERSTEIN, F; Daumer, M; Kaiser, R; Walter, H; Korn, K; Hoffmann, D; Oette, M; Rockstroh, J; Fatkenheuer, G; Perno, Cf; Lengauer, T
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs
2009-01-01 Alteri, C; Svicher, V; Gori, C; D'Arrigo, R; Ciccozzi, M; CECCHERINI SILBERSTEIN, F; Selleri, M; Bardacci, S; Giuliani, M; Elia, P; Scognamiglio, P; Balzano, R; Orchi, N; Girardi, E; Perno, Cf; Capobianchi, M; De Carli, G; Galati, V; Grisetti, S; Navarra, A; Nicastri, E; Pittalis, S; Puro, V; Sampaolesi, A; Nurra, G; Selleri, M; Zaccarelli, M; Zaniratti, M; Di Carlo, A; Giuliani, M; De Filippis, A; Brancatella, R; Maggi, T; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Battagin, G; Tacconi, L; Gallo, I; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing.
2022-01-01 Bellocchi, M; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; CECCHERINI SILBERSTEIN, F
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
| 2-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
| 1-lug-2016 | 48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study | Nozza, S; Pignataro, Ar; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A | Articolo su rivista | |
| 1-gen-2015 | A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. | Aragri, M; Coppola, N; Alteri, C; Battisti, A; Sagnelli, C; Pisaturo, M; Bellocchi, M; Salpini, R; Starace, M; Armenia, D; Carioti, L; Pollicita, M; Sagnelli, E; Perno, C; Svicher, V | Intervento a convegno | |
| 23-feb-2020 | A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro | Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V | Articolo su rivista | |
| 1-gen-2015 | A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy | Pollicita, M; Alteri, C; Bellocchi, M; Armenia, D; Carioti, L; Salpini, R; Colagrossi, L; Battisti, A; Aragri, M; Fabeni, L; Mariani, R; Dalessandro, M; Ranelli, A; Paoloni, M; Parruti, G; Perno, Cf; Svicher, V | Articolo su rivista | |
| 26-lug-2019 | A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection | Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V | Articolo su rivista | |
| 1-ago-2014 | A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. | Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, A; Calvez, V; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Santoro, M | Articolo su rivista | |
| 1-gen-2022 | Acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer, hampers HBsAg stability and secretion and promotes cell survival | Piermatteo, L; Carioti, L; Leoni, G; Duca, L; Saccomandi, P; Stella, D; Andreassi, E; Bertoli, A; Cappiello, G; Fleury, H; Svicher, V; Salpini, R | Articolo su rivista | |
| 1-gen-2023 | Amino acid variability of small molecule inhibitors and mAbs target sites in globally circulating RSV strains | Fox, V; Scutari, R; Salpini, R; La Frazia, S; Bandera, A; Priralla, A; Periani, E; Gori, A; Svicher, V; Alteri, C | Intervento a convegno | |
| 1-gen-2022 | An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. | Bellocchi, Mc; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F | Intervento a convegno | |
| 2-apr-2021 | An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression | Brancaccio, G; Salpini, R; Piermatteo, L; Surdo, M; Fini, V; Colagrossi, L; Cantone, M; Battisti, A; Oda, Y; Di Carlo, D; Ceccherini-Silberstein, F; Perno, Cf; Gaeta, Gb; Svicher, V | Articolo su rivista | |
| 22-giu-2013 | Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen | Cento, V; Van Hemert, F; Neumann Fraune, M; Mirabelli, C; Di Maio, V; Salpini, R; Bertoli, A; Micheli, V; Gubertini, G; Romano, S; Visca, M; De Sanctis, G; Berkhout, B; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V | Articolo su rivista | |
| 1-gen-2024 | Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy | Malagnino, V; Cozzi‐lepri, A; Svicher, V; Girardi, E; Perno, C; Saracino, A; Cuomo, G; Rusconi, S; Puoti, M; D'Arminio Monforte, A; Andreoni, M; Sarmati, L | Articolo su rivista | |
| 1-gen-2019 | CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy | Grande, F; Occhiuzzi, Ma; Rizzuti, B; Ioele, G; De Luca, M; Tucci, P; Svicher, V; Aquaro, S; Garofalo, A | Articolo su rivista | |
| 1-ott-2007 | Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors | CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf | Articolo su rivista | |
| 1-gen-2011 | Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. | Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf | Articolo su rivista | |
| 1-gen-2005 | Characterization of novel HIV drug resistance mutations using clustering, multidimensional scaling and SVM-based feature ranking | Sing, T; Svicher, V; Beerenwinkel, N; CECCHERINI SILBERSTEIN, F; Daumer, M; Kaiser, R; Walter, H; Korn, K; Hoffmann, D; Oette, M; Rockstroh, J; Fatkenheuer, G; Perno, Cf; Lengauer, T | Intervento a convegno | |
| 1-gen-2009 | Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs | Alteri, C; Svicher, V; Gori, C; D'Arrigo, R; Ciccozzi, M; CECCHERINI SILBERSTEIN, F; Selleri, M; Bardacci, S; Giuliani, M; Elia, P; Scognamiglio, P; Balzano, R; Orchi, N; Girardi, E; Perno, Cf; Capobianchi, M; De Carli, G; Galati, V; Grisetti, S; Navarra, A; Nicastri, E; Pittalis, S; Puro, V; Sampaolesi, A; Nurra, G; Selleri, M; Zaccarelli, M; Zaniratti, M; Di Carlo, A; Giuliani, M; De Filippis, A; Brancatella, R; Maggi, T; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Battagin, G; Tacconi, L; Gallo, I; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S | Articolo su rivista | |
| 1-gen-2022 | Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. | Bellocchi, M; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; CECCHERINI SILBERSTEIN, F | Articolo su rivista |